Epidarex Capital, a transatlantic life science venture firm, has acquired Sirakoss by OssDsign, a Swedish medtech company, for an initial cash consideration of $11 million plus milestone and royalty payments. Share this:FacebookXLike this:Like Loading... You May Also Like Healthcare Technology 30-08-2016 ACO Winners and Losers: a quick take Healthcare Technology 23-12-2021 EPtalk by Dr. Jayne 12/23/21 Healthcare Technology 13-01-2022 MedPAC declines to recommend to Congress additional pay bumps for doctors, hospitals Healthcare Technology 27-02-2022 Requesting Support on Interoperability, Health standards (HL7/ FHIR) and Health information exchange (HIE) for a Beginner